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Coronavirus replication requires proteolytic processing of the large polyprotein encoded by ORF1a/ab into
putative functional intermediates and eventually 15 mature proteins. The C-terminal ORF1a protein nsp10
colocalizes with viral replication complexes, but its role in transcription/replication is not well defined. To
investigate the role of nsp10 in coronavirus transcription/replication, alanine replacements were engineered
into a murine hepatitis virus (MHV) infectious clone in place of conserved residues in predicted functional
domains or charged amino acid pairs/triplets, and rescued viruses were analyzed for mutant phenotypes. Of
the 16 engineered clones, 5 viable viruses were rescued, 3 mutant viruses generated no cytopathic effect but were
competent to synthesize viral subgenomic RNAs, and 8 were not viable. All viable mutants showed reductions
in growth kinetics and overall viral RNA synthesis, implicating nsp10 as being a cofactor in positive- or
negative-strand synthesis. Viable mutant nsp10-E2 was compromised in its ability to process the nascent
polyprotein, as processing intermediates were detected in cells infected with this virus that were not detectable
in wild-type infections. Mapping the mutations onto the crystal structure of severe acute respiratory syndrome
virus nsp10 identified a central core resistant to mutation. Mutations targeting residues in or near either
zinc-binding finger generated nonviable phenotypes, demonstrating that both domains are essential to nsp10
function and MHV replication. All mutations resulting in viable phenotypes mapped to loops outside the
central core and were characterized by a global decrease in RNA synthesis. These results demonstrate that
nsp10 is a critical regulator of coronavirus RNA synthesis and may play an important role in polyprotein
processing.
Coronaviruses (CoVs) have historically been associated with
severe disease in important domestic animals and mild upper
respiratory tract infections in humans (human CoV strains
HCoV-229E and HCoV-OC43), rarely leading to severe dis-
ease (24). However, the rapid identification of a CoV as the
etiological agent responsible for severe acute respiratory syn-
drome (SARS) redefined historic perceptions. SARS-CoV
spread globally and infected over 8,000 people, with mortality
rates of about 10% (49). More recent studies have identified
human CoVs NL63 and HKU-1 as being important lower res-
piratory tract pathogens (25, 53). With ubiquitous populations
of CoVs found in many animals, it is not surprising that several
newly identified CoVs that likely emerged from zoonotic res-
ervoirs over the past 20 years have been described. An under-
standing of the basic biology and pathogenesis of CoV infection is
of urgent importance.
CoVs are the largest known RNA viruses encoding plus-
sense, 5-capped, and polyadenylated genomes of 27 to 31 kb in
length. CoVs are classified as members of the order Nidovi-
rales, family Coronaviridae, genus Coronavirus, and are divided
into three groups based on serological and phylogenetic cate-
gorizations (14, 29). Group 1 consists of NL63, HCoV-229E,
and transmissible gastroenteritis virus; group 3 is composed of
infectious bronchitis virus; and group 2 CoVs include HCoV-
OC43, HKU-1, bovine CoV, SARS-CoV, and murine hepatitis
virus (MHV) (14). MHV is an extensively studied CoV, with
strain MHV-A59 being well characterized in cell culture and
mouse model systems (33). The close relationship of MHV to
SARS-CoV makes MHV an ideal model for prototype studies
of the biology and pathogenesis of CoV infections in humans.
The first 22 kb of the CoV genome is organized as two
overlapping open reading frames (ORFs), which encode the
replicase genes (ORF1a and ORF1ab), while the remaining 5
to 9 kb contains the genes that encode (i) structural proteins
common to all CoVs, including spike (S), envelope (E), matrix
(M), and nucleocapsid (N) proteins, and (ii) accessory ORFs
that encode proteins unique to specific virus groups (24). The
structural and accessory proteins are encoded by a nested set
of coterminal subgenomic mRNAs that are generated by dis-
continuous transcription of negative strands (1, 21, 39, 40, 42–44,
46, 57), followed by positive-strand synthesis and then transla-
tion.
Immediately after entry, the genomic RNA is uncoated, and
the translation of ORF1 generates either a 500-kDa polypro-
tein (pp1a) from ORF1a or an 800-kDa polyprotein (pp1ab),
which is translated only when the ORF1a stop codon is over-
ridden by a 1 ribosomal frameshift that allows the translation
of an ORF1ab fusion protein (5). ORF1ab translation occurs
at an approximate frequency of 25 to 30%, which leads to a
greater-than-threefold enrichment of proteins translated from
pp1a (4). During and after translation, pp1a and pp1ab are
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processed by three functionally active virally encoded protein-
ases into active intermediates and eventually 15 mature pro-
teins (6).
Two distinct types of viral proteinases are required to pro-
cess the nascent polyprotein into component intermediates
and mature proteins. The first type is the Papain-like protein-
ases (PLP1 and PLP2), which cleave nonstructural proteins
(nsp1 to nsp3) cotranslationally (7, 8, 18, 45), resulting in
mature proteins nsp1, nsp2, and nsp3 as well as polyproteins
nsp4 to 11 and nsp4 to 16. These polyprotein intermediates are
then processed both cotranslationally and posttranslationally
by the second type, a 3C-like proteinase known as 3CLpro or
main proteinase (Mpro) (11). Although the exact order and
mechanism of processing of mature proteins from these inter-
mediates are yet to be determined, most of these proteins have
been observed in their mature form and colocalize with the
viral RNA-dependent RNA polymerase to intracellular dou-
ble-membrane vesicles, where they form the viral replication
complex (16). The current model suggests that larger unproc-
essed intermediates such as nsp4-10/11 (p150) play a role in
early negative-strand synthesis, while positive-strand replica-
tion is thought to require mature proteins (41). To date, only
nsp2 has been shown to be dispensable for replication (17).
In general, nsp1 and nsp2 have unknown functions, nsp3
contains domains important for transcriptional regulation as
well as for PLP1 and PLP2 activity, nsp4 and nsp6 are trans-
membrane domains that may aid in anchoring the replication
complex to double-membrane vesicles, and nsp5 is the 3CLpro.
nsp7 to nsp10 are four small proteins of unknown function
found at the carboxy-terminal end of pp1a. The structures of
nsp7 (34) nsp7-nsp8 (56), nsp9 (13, 52), and nsp10 (22, 51)
have been solved, and all four proteins have been implicated in
RNA synthesis. nsp7 and nsp8 are predicted to form a hollow
cylinder postulated to protect double-stranded RNA during
transcription/replication (56), nsp8 has a demonstrated RNA
primase activity (20), nsp9 has been shown to bind single-
stranded RNA (13, 52), and three studies with nsp10 predict
that it interacts with RNA, DNA, and/or other proteins (22, 28,
51). nsp11 is a small 36-nucleotide (nt) segment located at
the 3 end of ORF1a that encodes a small uncharacterized
12-amino-acid peptide with no defined function. nsp12 is the
RNA-dependent RNA polymerase (RdRp), nsp13 contains
the helicase activity, and nsp14 to nsp16 are enzymes that may
function in RNA processing (48).
Studies with nsp10 have shown that it is a 15-kDa protein of
unknown function that has been shown to interact with itself,
nsp1, and nsp7 (8). It colocalizes with N to sites of viral rep-
lication (3) and is essential for replication (D. Deming et al.,
unpublished data). nsp10 was first predicted to be a possible
growth factor-like molecule, as the concentration of nsp10
increased in response to epidermal growth factor (30); how-
ever, there is little homology between nsp10 and any other
proteins of known function. Complementation studies using
temperature-sensitive mutants in several nsp’s of MHV have
purported that nsp10, along with nsp4, nsp5, nsp12, nsp14, and
nsp16, is essential for the assembly of a functional replication/
transcription complex (41). Further characterization of the
nsp10 temperature-sensitive mutant TS-LA6 has suggested
that nsp10 plays a critical role in negative-strand elongation
(41, 47, 54). Recent crystallography studies have revealed the
structure of nsp10 of SARS-CoV to be a novel zinc finger
protein with two zinc finger domains (22, 51), whereas a second
report suggested that the biological unit is a dodecamer that
forms a hollow, positively charged cylinder that is thought to be
a transcription factor (22, 51).
In this study, we employed a reverse-genetics approach to
generate mutants of nsp10 in the context of the entire virus to
define the functions of nsp10 in CoV replication/transcription.
We show that rescued viruses with mutations in nsp10 globally
reduce viral RNA synthesis. Mutations resulting in lethal phe-
notypes mapped to a central core of nsp10 that is resistant to
mutation and verified that the zinc-binding fingers (ZFs), in-
cluding the surrounding residues to which they hydrogen bond,
are critical to nsp10 function and CoV viability. Finally, our
study is the first study to demonstrate that mutations in nsp10
may affect the processing of the ORF1a/ORF1ab polyprotein.
MATERIALS AND METHODS
Virus and cells. For this study, we used an infectious clone of MHV-A59
developed by our laboratory, which is comprised of seven fragments maintained
in pSMART (Lucigen) or pCR-XL-TopoA (Invitrogen) vectors and was ampli-
fied according to previously published protocols (55). Recombinant MHV gen-
erated by the infectious clone (wt-icMHV) was used as a control in each exper-
iment. The MHV sequence under GenBank accession number NC_001846 was
used for primer and cloning design.
Delayed brain tumor (DBT) cells were maintained at 37°C in minimum es-
sential medium supplemented with 10% fetal clone II (Gibco), 10% tryptose
phosphate broth, and gentamicin (0.05 g/ml)-kanamycin (0.25 g/ml). Baby
hamster kidney (BHK) cells exogenously expressing MHV receptor (MHVr)
(BHK-MHVr) were maintained at 37°C in the same medium described above
with the addition of geneticin (0.8 mg/ml) to select for cells expressing MHVr.
Bioinformatics analysis and mutant rationale. A multiple sequence alignment
generated by the National Center for Biotechnology Information (NCBI) (http:
//www.ncbi.nlm.nih.gov/genomes/SARS/nsP7.html) was used to map the con-
served features of nsp10. Bioinformatic predictions were generated using Prosite
(19) to predict conserved protein domains, Predictors of Natural Disordered
Regions (38) to determine putative disordered domains, the SMART database
(26) to search for similarity signatures, and HMMSearch (12) to analyze poten-
tial structurally conserved subunits.
Generating mutants. A full-length molecular clone developed by our labora-
tory (55) was used to engineer the appropriate mutations in the nsp10 sequence,
which is found in the MHV-E fragment (55). Briefly, primers that incorporated
type IIS restriction enzyme sites (BbsI) bearing each mutation onto the ends of
two amplicons that comprised MHV-E (55) were designed (Table 1). In all cases,
the wild-type residue(s) was changed to alanine by altering two positions in each
codon. The mutants were generated by PCR, cloned into the Topo-XL vector
(Invitrogen), grown up in competent Top10 cells (Invitrogen), screened by re-
striction digestion, and sequenced to verify that the correct changes were added
onto each end. Each amplicon was then digested with BbsI and ligated to form
the mutated MHV-E fragment. Full-length E constructs were amplified and
purified, and the sequence was verified. For assembling the infectious clone,
plasmids incorporating cDNA fragments of MHV-A through MHV-G for wt-
icMHV and MHV-A to MHV-D, MHV-F, MHV-G, and the mutated E con-
struct for each mutant were transformed into chemically competent Top10 cells
(Invitrogen) by heat shock at 42°C for 2 min and then plated onto Luria Bertani
(LB) plates with appropriate selection (kanamycin [25 g/ml] for Topo-XL and
ampicillin [50 g/ml] for pSMART). Colonies were picked and grown under
appropriate selection conditions in 5 ml of LB broth maintained at 28.5°C for 16
to 24 h and then purified and screened by restriction digestion. Larger 20-ml
stocks were grown at 28.5°C for 24 h for each of the cDNAs. Purified plasmids
were then digested with MluI and BsmBI for MHV-A; BglI and BsmBI for
MHV-B and MHV-C; BsmBI for MHV-D, MHV-E, and MHV-F; and SfiI and
BsmBI for MHV-G (55). After digestion, fragments were electroporated on an
0.8% agarose gel, and appropriate bands were excised and gel purified using a
Qiaex II gel extraction kit (QIAGEN) with modifications (55). Briefly, all frag-
ments were resuspended in 620 l of QX1 buffer, 11 l QIAEX II silica gel
particles, and 12.5 l 3 M sodium acetate and eluted in 35 l of elution buffer
heated to 70°C. Purified fragments were ligated overnight at 4°C in a total
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reaction mixture volume of 200 l. The full-length cDNA was then further
purified by chloroform extraction and isopropanol precipitation, transcribed
using T7 transcription kit (Ambion), and cotransfected into 8  106 BHK-MHVr
cells in parallel with the N gene driven by an SP6 promoter and transcribed with
an SP6 transcription kit (Ambion). Electroporated BHK cells were poured onto
2.5  105 DBT cells seeded in T75 flasks and incubated at 37°C for 24 to 72 h.
Flasks were examined at regular intervals for cytopathic effects (CPEs), and
viable mutants were verified by reverse transcriptase PCR (RT-PCR) of sub-
genomic RNA using primers targeting the leader sequence and the 5 end of the
N gene (Table 1). Plaque-purified viruses were sequenced to confirm that the
correct mutations were present in the recombinant virus.
Growth kinetics and RNA analysis. Viral stocks were propagated in DBT cells
for each viable mutant, and titers were determined by plaque titration. For
growth curve analysis, DBT cells were infected at a multiplicity of infection
(MOI) of 0.2 PFU/cell in 60-mm plates with a 1-h adsorption period, followed by
three washes with phosphate-buffered saline (PBS). Three milliliters of medium
was added to each culture, and the infection was maintained at 37°C. Superna-
tants were harvested at 2, 4, 8, 12, and 16 h postinfection (p.i.), and titers were
determined by plaque titration in DBT cells. For analysis of RNA, cells were
infected at an MOI of 1 PFU/cell, and total RNA was harvested at 8 and 12 h in
TRIzol reagent (Invitrogen). For Northern blot analysis, 1 g of total RNA from
each mutant and wt-icMHV was separated by gel electrophoresis on a 1%
agarose gel, transferred onto a nitrocellulose membrane, and probed with a
300-nt biotinylated RNA probe designed to detect the first 300 nt of mRNA-7
(N gene) using an Ambion (Austin, TX) Northern kit. Bands were detected using
the Bright Star Detection (Ambion) system, and membranes were exposed to
film.
Reverse transcription, RT-PCR, and real-time PCR. Viral RNA was reverse
transcribed to cDNA using SuperScript III (Invitrogen) with modifications to the
protocol as follows. Random hexamers (300 ng) and total RNA (5 g) were
incubated for 10 min at 70°C. The remaining reagents were then added according
to the manufacturer’s recommendations, and the reaction mixture was incubated
at 55°C for 1 h, followed by 20 min at 70°C to deactivate the RT. For RT-PCR,
a forward primer in the leader sequence and a reverse primer 200 nt into the
N gene (Table 1) were used to generate a 220-bp product by PCR.
Quantitative real-time RT-PCR was conducted using Smart Cycler II (Ceph-
eid) with SYBR green (diluted to 0.25; Cepheid) to detect subgenomic cDNA
with primers (7.5 pmol) optimized to detect 120 nt spanning from the leader
sequence to the 5 end of the N gene (Table 1) or genomic cDNA with primers
(7.5 pmol) optimized to detect 120 nt of ORF1a (Table 1). The cDNA from the
RT reaction mixture of each virus was diluted 1:103, and 1 l was used for each
reaction mixture, with a total reaction mixture volume of 25 l. Omnimix beads
(Cepheid) containing all reagents except SYBR green, primer, and template
were used to standardize the reaction conditions, and template concentrations
were normalized by concentrations of the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). In addition, all products were verified by
melting curve analysis.
Statistical methods. Three independent infections for each mutant were an-
alyzed by real-time PCR, and differences in copy numbers for genomic and
subgenomic RNAs were tested using the paired t test with an  value of 0.05.
Immunoprecipitation analysis. DBT cells were infected at an MOI of 2
PFU/ml for 2 h, at which time the medium was removed and replaced with
medium lacking Met-Cys but containing 20 g/ml of actinomycin D (Sigma) and
incubated at 37°C for an additional 2 h. At 4 h p.i., [35S]methionine-cysteine
TABLE 1. Primers used for engineering nsp10 mutants and RT-PCR
Primer Sequence (5–3) Sense Purpose
nsp10-E1S GAAGACGCGGCAACGTACTTGGATTATATAAAACAG  Mutant nsp10-E1
nsp10-E1A GAAGACGTTGCCGCAGGATCTACAGAAAACGCACAC  Mutant nsp10-E1
nsp10-E2S GAAGACGCGGCAGCTGGCACTGGTATGGCCATTAC  Mutant nsp10-E2
nsp10-E2A GAAGACGCTGCCGCACATAACATCTTAACACAATTAG  Mutant nsp10-E2
nsp10-E4S GAAGACGCGGCAGCGGTTGAACATCCAGATGTTGATG  Mutant nsp10-E4
nsp10-E4A GAAGACGCTGCCGCGCAATATATACAAACGGAAGCACC  Mutant nsp10-E4
nsp10-E5S GAAGACGCGGCACCAGATGTTGATGGATTGTGC  Mutant nsp10-E5
nsp10-E5A GAAGACGGTGCCGCAACACGCGAGCGGCAATATATAC  Mutant nsp10-E5
nsp10-E6S GAAGACGCGGCACCTGTGTCATATGTGTTGACG  Mutant nsp10-E6
nsp10-E6A GAAGACGGTGCCGCTATGCCTAAGGGCACTTGGAC  Mutant nsp10-E6
nsp10-E7S GAAGACGCGGCAGTTTGTCAGGTTTGTGGCTTTTGG  Mutant nsp10-E7
nsp10-E7A GAAGACACTGCCGCCGTCAACACATATGACACAG  Mutant nsp10-E7
nsp10-E8S GAAGACGCGGCAGGTAGCTGTTCCTGTGTAGGC  Mutant nsp10-E8
nsp10-E8A GAAGACCCTGCCGCCCAAAAGCCACAAACCTGAC  Mutant nsp10-E8
nsp10-U1S GAAGACGCAGTTAAGATGTTATGTGACCATGCTGGC  Mutant nsp10-U1
nsp10-U1A GAAGACTTAACTGCATTAGTAACGGGAACTCCACCCTGTTT  Mutant nsp10-U1
nsp10-U2S GAAGACGCAATGGCCATTACTATTAAGCCGGAGGCA  Mutant nsp10-U2
nsp10-U2A GAAGACGCCATTGCAGTGCCAGCATGGTCACATAACATCTT  Mutant nsp10-U2
nsp10-U3S GAAGACGCAATTAAGCCGGAGGCAACCACTAATCAG  Mutant nsp10-U3
nsp10-U3A GAAGACTTAATTGCAATGGCCATACCAGTGCCAGCATGGTC  Mutant nsp10-U3
nsp10-U4S GAAGACGCAGAGGCAACCACTAATCAGGATTCTTAT  Mutant nsp10-U4
nsp10-U4A GAAGACGCCTCTGCCTTAATAGTAATGGCCATACCAGTGCC  Mutant nsp10-U4
nsp10-U5S GAAGACGCAGCTTCCGTTTGTATATATTGCCGCTCG  Mutant nsp10-U5
nsp10-U5A GAAGACGAAGCTGCACCATAAGAATCCTGATTAGTGGTTGC  Mutant nsp10-U5
nsp10-U6S GAAGACGCAACTGGTATGGCCATTACTATTAAGCCG  Mutant nsp10-U6
nsp10-U6A GAAGACCCAGTTGCAGCATGGTCACATAACATCTT  Mutant nsp10-U6
nsp10-U7S GAAGACGCAGGTGGTGCTTCCGTTTGTATATATTGC  Mutant nsp10-U7
nsp10-U7A GAAGACCCACCTGCAGAATCCTGATTAGTGGTTGC  Mutant nsp10-U7
nsp10-U8S GAAGACGCAGGTGCTTCCGTTTGTATATATTGCCGC  Mutant nsp10-U8
nsp10-U8A GAAGACGCACCTGCATAAGAATCCTGATTAGTGGT  Mutant nsp10-U8
nsp10-U9S GAAGACGCAGTTTGTATATATTGCCGCTCGCGTGTT  Mutant nsp10-U9
nsp10-U9A GAAGACCAAACTGCAGCACCACCATAAGAATCCTG  Mutant nsp10-U9
nsp10-MS ACAGGGTGGAGTTCCCGTTA  PCR and sequencing nsp10
nsp10-MA CCTAAGGGCACTTGGACAAA  PCR and sequencing nsp10
Sg-N1S AAGAGTGATTGGCGTCCGTA  RT and PCR
Sg-N1A AGCGCGGTTTACAGAGGAG  RT and PCR
N-gene-S ATGTCTTTTGTTCCTGGGCAAG  Northern probe
N-gene-A GCAGTAATTGCTTCTGCTG  Northern probe
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(0.08 mCi/ml) was added to the infections, and cells were harvested at 9 h. Radio-
labeled cells were washed in 1 ml of PBS and then resuspended in 1 ml of cold
ST buffer (200 mM sucrose, 10 mM Tris [pH 7.4]). Next, cells were homogenized
by 40 passes through a ball-bearing homogenizer and transferred into fresh
tubes. Homogenates were then spun at 6,000  g for 3 min at room temperature,
and the supernatant was transferred into ultracentrifuge tubes and spun at
300,000  g for 15 min at 4°C. The supernatant was then transferred into a fresh
tube (S100), and the pellet was resuspended in 1 ml of ST buffer (P100). The
nuclear pellet was resuspended in 1 ml of ST buffer, and the DNA was sheared
by passage 20 times through a 20-gauge needle.
Lysates were boiled for 5 min in sodium dodecyl sulfate (SDS) at a final
concentration of 1% and then combined with protein A-Sepharose beads and a
1:200 dilution of anti-nsp10 antibody (VU128) in no-SDS lysis buffer (1% NP-40,
150 mM sodium chloride, 0.5% sodium deoxycholate, and 50 mM Tris [pH 8.0])
supplemented with 1% SDS. After incubation at 4°C for 4 h, beads were pelleted
and washed with low-salt lysis buffer (no-SDS lysis buffer plus 150 mM NaCl),
followed by high-salt lysis buffer (no-SDS lysis buffer with 1 M NaCl) and a final
low-salt wash. After rinsing, 30 ml of 2 SDS loading buffer (8% SDS, 0.2 M Tris
[pH 8.8], 4 mM EDTA, 0.1% bromophenol blue, 40% glycerol, 0.5 M dithio-
threitol) was added to the pelleted beads and boiled for 5 min prior to electro-
phoresis of the supernatant on 4 to 12% SDS-polyacrylamide gel electrophoresis
(PAGE) gels.
IFA. DBT cells were grown to 60 to 70% confluence on 12-mm glass coverslips
and infected with wt-icMHV or each of the viable mutants at an MOI of 5
PFU/cell. At 6.5 h p.i., the medium was aspirated, and the cells were fixed and
permeabilized in methanol overnight at 20°C. Cells were rehydrated in PBS for
30 min and blocked in buffer comprised of PBS with 5% bovine serum albumin.
All subsequent immunofluorescence assay (IFA) steps were conducted at 25°C in
IFA wash buffer comprised of PBS containing 1% bovine serum albumin and
0.05% Nonidet P-40. After blocking, cells were incubated in primary antibody
(anti-nsp10 [VU128] diluted 1:200 and anti-N diluted 1:1,000 or anti-M diluted
1:1,000) for 1 h. Cells were then washed in IFA wash buffer three times at 10
min/wash. Next, cells were incubated in secondary antibody (goat anti-rabbit
Alexa 488 at a dilution of 1:1,000 and goat anti-mouse Alexa 546 at a dilution of
1:1,000; Molecular Probes) for 45 min. Next, cells were washed three times at 10
min/wash, followed by a final wash of 30 min in PBS. Coverslips were mounted
onto slides with Aquapolymount (Polysciences), dried for 1 h, and then visual-
ized by confocal immunofluorescence microscopy using a Zeiss LSM 510 laser
scanning confocal microscope at 488 and 543 nm with a final magnification
of 40 with the oil immersion lens. Images were prepared for publication using
Adobe Photoshop CS.
Analysis of structure. The crystal structure coordinates of SARS nsp10 (PDB
accession number 2FYG) (22) were used as a template to generate a homology
model of MHV nsp10, which is a predicted three-dimensional structure of this
protein calculated from its sequence homology with SARS-CoV nsp10. Homol-
ogy models were generated using the program Modeler, version 8.2 (15, 27), with
the automodel class. A pairwise alignment was generated using the SARS nsp10
protein database (PDB) file and the MHV homologue sequence (GenBank
accession number NP_740615), and five models were generated from each align-
ment, with the best model selected based on the lowest objective-function score.
Corresponding PDB files generated by this program were visualized using the
molecular modeling tools MacPyMol (DeLano Scientific) and Chimera (35). In
addition, homology models of each of 16 mutants were generated using the same
parameters.
RESULTS
Mutation design and rationale. To identify functional do-
mains within MHV nsp10 and determine the roles that nsp10
plays in CoV replication, two different alanine-scanning mu-
tagenesis strategies were devised. The first strategy targeted
pairs and triplets of charged amino acids, since charged resi-
dues often provide electrostatic surface potential required for
the interaction of the protein with other proteins or nucleic
acids. These sites may play a crucial role in inter- and intra-
protein interactions as well as nucleic acid binding, and these
were designated the E-series mutants (Table 2 and Fig. 1).
Bioinformatic methods identified an highly active region
from amino acids 50 to 75 that contains multiple predicted
protein domains and a disordered region potentially indicative
of an interaction domain (Fig. 1 and Table 2). The disordered
region was not conserved at the amino acid level; however, the
same amino acid positions were predicted by Predictors of
TABLE 2. Sites targeted for mutagenesis
Mutant aa position(s) Conservation Phenotype Structural location
nsp10-E1 K24 K25 KK in GII,a not in SARS; K25 in mostb Viable N terminus of H2c
nsp10-E2 D47 H48 DH in GII, H also in GId Viable Loop between H2 and H3
nsp10-E4 R78 S79
R80
R78 strictly conserved,e position 80 always f Lethal H4 near ZF-1
nsp10-E5 E82 H83 Position 82 mostlyb ,f H83 identical in CoVs Lethal ZF-1
nsp10-E6 K104
D105
D strictly conserved Lethal Near N terminus of H5
nsp10-E7 H113
D114
Mostly  at position 114, H113 identical in GII Lethal C terminus of H5 near ZF-2
nsp10-E8 D123
R124
Conserved in GII,  at position 124 also in SARS Lethal C-terminal loop near ZF-2
nsp10-U1 C41 Strictly conserved in CoVs Viable Loop between H2 and H3
nsp10-U2 G52 Strictly conserved in CoVs Viable-Dg Loop between B1h and B2
nsp10-U3 T56 Strictly conserved in CoVs Viable Loop between B1 and B2
nsp10-U4 P59 Variable in CoVs Viable B3
nsp10-U5 G70 Strictly conserved in CoVs Viable-D H3
nsp10-U6 G50 Strictly conserved in CoVs Viable-D Loop between B1 and B2
nsp10-U7 Y68 Conserved aromatic in CoVs Lethal H3
nsp10-U8 G69 Strictly conserved in CoVs Lethal H3
nsp10-U9 S72 Strictly conserved in CoVs Lethal H3
a GII, group II CoVs.
b Mostly conserved indicates some amino acid conservation but not in every group.
c H, -helix.
d GI, group I CoVs.
e Strictly conserved means identical.
f  indicates positive charge, and  indicates negative charge.
g D, debilitated.
h B, -sheet.
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Natural Disordered Regions (38) to be disordered in all CoVs,
indicating that the conserved disordered region may play an
important role in nsp10 function. Therefore, the second strat-
egy targeted key residues in this region of nsp10 in an attempt
to alter potential protein-protein or protein-nucleic acid inter-
action sites (Table 2 and Fig. 1) (38) or ablate putative func-
tional domains (myristoylation sites, phosphorylation sites,
etc.) (Table 2 and Fig. 1). These mutants were designated the
U-series mutants. All U-series mutant amino acids were con-
served in nsp10 in all three groups of the Coronavirus genus
(Fig. 1 and Table 2), except mutant nsp10-U4, which targeted
a nonconserved proline present in MHV and SARS-CoV. This
change was predicted to add order to the conserved disordered
region.
To determine the effects of nsp10 alanine-scanning mu-
tagenesis on MHV replication, the 16 mutations were engi-
neered into the molecular clone of MHV, replacing the wild-
type amino acid(s) with alanine. In all cases, two nucleotide
changes were made to each codon to reduce the likelihood of
reversion to the wild-type sequence. The wild-type fragments
of the molecular clone were isolated by restriction endonucle-
ase digestion and ligated with the appropriate sequence-veri-
fied mutant fragment, and full-length cDNAs were then tran-
scribed in vitro, transfected into replication-competent cell
lines, and monitored for CPE, i.e., syncytium formation (55).
Isolation and genotype of mutant viruses. MHV mutant
viruses containing the mutations nsp10-U1, nsp10-U3, nsp10-
U4, nsp10-E1, and nsp10-E2 were rescued by 48 h posttrans-
fection and were categorized as the viable mutants. Mutant
nsp10-U1 grew with characteristics similar to those of wt-icMHV,
with plaque formation and size comparable to those of the
wild-type virus. Mutants nsp10-U3 and nsp10-U4 had re-
duced plaques sizes compared to wt-icMHV. Mutant
nsp10-E1 exhibited smaller plaque sizes, with irregular bound-
aries, whereas viable mutant nsp10-E2 was the most difficult
to observe in further analyses due to variably sized plaques
with irregular borders and sizes, many of which were much
smaller than those of the wild type (2 mm versus 5 mm)
and barely visible to the eye.
Mutants nsp10-U2, nsp10-U5, and nsp10-U6 exhibited a
CPE-negative, RNA positive (CPE/RNA) phenotype char-
acterized by no detectable CPE in the transfection flask by 48 h
posttransfection, although all three generated subgenomic
mRNAs at a cycle threshold slightly above the lower limit of
detection by real-time PCR (data not shown). However, lead-
er-containing transcripts could not be detected after passage of
nsp10-U2 and nsp10-U6. Interestingly, by 72 h posttransfec-
tion, nsp10-U5 infections showed signs of CPEs. Sequencing of
nsp10-U5 from cells harvested at 48 h posttransfection con-
firmed the correct mutation (G70A), while sequences gener-
ated from infections harvested after 72 h demonstrated a wild-
type genotype at the mutant locus. This was repeated with the
exact results both times, suggesting that nsp10-U5 reverts to
the wild type at two nucleotide positions after 48 h of debilitated
replication. Mutants nsp10-E4, nsp10-E5, nsp10-E6, nsp10-E7,
nsp10-E8, nsp10-U7, nsp10-U8, and nsp10-U9 were nonviable,
as multiple attempts failed to recover virus or detect leader-
containing transcripts.
All of the viable mutants nsp10-U1, nsp10-U3, nsp10-U4,
nsp10-E1, and nsp10-E2 were plaque purified and sequenced
at the nsp10 locus to confirm that the appropriate mutant allele
had been incorporated into the molecular clone, and stocks
were grown to a high titer for further analyses.
Phenotype analyses. To determine the effects of the nsp10
mutations on viral growth kinetics and global viral RNA synthesis,
we compared rescued mutant nsp10 viruses to wt-icMHV via
viral growth curves, Northern blot analysis, and quantitative
PCR. DBT cells were infected with wild-type or recombinant
viruses bearing the viable nsp10 mutations at an MOI of 0.2
PFU/cell for 1 h, and virus growth was assayed over 16 h. All
five viable mutants grew to lower titers than did wt-icMHV at
all time points up to 16 h p.i. (Fig. 2A). However, nsp10-U1
growth was roughly equivalent to that of the wild-type virus,
while the other four mutants displayed lower titers at 8 h p.i.
FIG. 1. Mutational design of nsp10 mutants. nsp10 mutants were selected using two approaches. The U series of mutants targeted conserved
residues in putative regulatory motifs near a predicted disordered region, and the E-series mutants targeted charged amino acid pairs and triplets.
Residues above the black box are predicted to comprise a disordered region. TGEV, transmissible gastroenteritis virus; PEDV, porcine epidemic
diarrhea virus; BCoV, bovine CoV; IBV, infectious bronchitis virus.
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By 12 and 16 h p.i., mutants nsp10-E1 and nsp10-E2 were
debilitated, replicating to titers about 1 log lower than those of
the wild type, while mutants nsp10-U3 and nsp10-U4 were
characterized as having more extensive blocks in virus replica-
tion (Fig. 2A). As overall virus growth was reduced for many of
the nsp10 mutant viruses, we next evaluated levels of sub-
genomic viral transcripts using Northern blotting (Fig. 2B) and
subgenomic and genomic RNA levels using real-time PCR
(Fig. 3B, C, and D).
By Northern blotting, all mutants showed a reduction in
subgenomic mRNA synthesis at 8 h p.i., with nsp10-E1, nsp10-
E2, and nsp10-U4 showing more extensive blocks in sub-
genomic mRNA synthesis. nsp10-E2 showed an inordinate re-
duction in subgenomic mRNA synthesis compared to all other
mutants and wt-icMHV at 8 h p.i. (Fig. 2B).
To confirm and extend the Northern blot analysis, real-time
PCR was used to quantify viral plus-strand transcripts using
primers designed to amplify subgenomic RNA from the N
gene or genomic RNA from ORF1a. In agreement with the
Northern blot data, quantitative PCR analyses demonstrated
that all five mutants were reduced in subgenomic mRNA syn-
thesis at 8 h p.i. compared to wt-icMHV, with more extensive
blocks occurring in mutants nsp10-E2, which had a 900-fold
reduction, and nsp10-U4, with a 60-fold reduction in mRNA
synthesis (Fig. 3B and D). All other mutants had reductions of
less than 10-fold (Fig. 3D). Analysis of genomic RNA showed
the same trend, with reductions in all mutants, while nsp10-E1
showed an approximately 7-fold reduction, nsp10-E2 showed a
900-fold reduction, and nsp10-U4 showed a 17-fold reduction
in genomic RNA at 8 h p.i compared to wt-icMHV (Fig. 3C
and D). All other mutants were reduced by less than 10-fold
(Fig. 3D).
A comparison of the reductions of subgenomic and genomic
RNAs at 8 h p.i. demonstrated that mutants nsp10-E2 and
nsp10-U1 had equivalent reductions of both genomic and sub-
genomic RNAs (Fig. 3D). nsp10-E2 had reductions of 900-fold
in both genomic and subgenomic RNAs, whereas nsp10-U1
had 2-fold reductions of both (Fig. 3D).
In contrast, nsp10-E1, nsp10-U3, and nsp10-U4 showed dif-
ferential effects on subgenomic and genomic RNA synthesis
(Fig. 3D). nsp10-E1 showed a larger reduction in subgenomic
than genomic RNA synthesis, with a 7-fold reduction versus a
3.5-fold reduction, respectively, although this difference was
not statistically significant (P value of 0.11). Furthermore,
nsp10-U3 and nsp10-U4 demonstrated greater reductions in
genomic RNA than subgenomic mRNAs (Fig. 3D). In the case
of nsp10-U3, genomic RNA was reduced 3.5-fold, while sub-
genomic mRNA was reduced only 2-fold, and this difference
was statistically significant, with a P value of 0.043. nsp10-U4
also showed a greater decrease in genomic RNAs, with a 60-
fold reduction, versus subgenomic mRNA synthesis, with a
17-fold reduction (Fig. 3D). This difference was statistically
significant, with a P value of 0.024.
However, by 12 h p.i., only steady-state levels of nsp10-E2
RNA were significantly reduced compared to those of wt-
icMHV. While nsp10-U4 also displayed slightly reduced levels
FIG. 2. Growth kinetics and Northern blot analysis of nsp10 mutants. (A) Cultures of DBT cells were infected at an MOI of 0.2 PFU/cell. Virus
samples were taken at different time points and measured by plaque assay. All mutants showed reduced growth kinetics at 8 h p.i, while nsp10-U1
recovered by 12 h p.i. to nearly wt-icMHV growth levels. All other viable mutants reached lower titers, with nsp10-U3 and nsp10-U4 showing a
2-log difference at 16 h p.i. Filled square, wt-icMHV; , nsp10-E1; filled triangle, nsp10-E2; filled diamond, nsp10-U1; hollow square, nsp10-U3;
filled circle, nsp10-U4. (B) Northern blot. Cultures of cells were infected at an MOI of 1 PFU/cell, and intracellular RNA was isolated at 8 h p.i.
The RNA was separated on 1% agarose gels, blotted onto a nitrocellulose membrane, and probed with an N-gene-specific probe. The results show
that all five mutants have reduced RNA synthesis compared to wt-icMHV, whereas two mutants, nsp10-E1 and nsp10-E2, have reduced
subgenomic RNA at 8 h p.i. G, genomic; H, hemagglutinin esterase; S, spike; E, envelope; M, membrane; N, nucleocapsid.
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of subgenomic RNA compared to those of wt-icMHV, all other
mutants had recovered viral RNA synthesis to wt-icMHV levels.
nsp10-E2 maintained a 3-log reduction through both time
points.
These results suggest that in general, mutations in nsp10
result in global attenuation of viral RNA synthesis, particularly
early in infection. In addition, some mutations demonstrate
greater defects in genomic and/or subgenomic mRNA synthe-
FIG. 3. Real-time PCR analysis of nsp10 mutants. Three independent cultures of DBT cells were infected for each of the nsp10 mutants or
wt-icMHV at an MOI of 1 PFU/cell and harvested at 8 and 12 h p.i. Total RNA was isolated, reverse transcribed using random hexamers, and
amplified by real-time PCR using primers specific for genomic or subgenomic cDNAs or the housekeeping gene GAPDH. (A) Total RNA for each
sample was normalized to GAPDH levels by diluting samples until cycle threshold values, as determined by real-time PCR, were roughly
equivalent, indicating equivalent concentrations of starting template. (B) Subgenomic mRNAs for the N gene of wt-icMHV and the viable mutant
panel were compared, and in agreement with the Northern blot analysis, all five viable mutants showed decreases in subgenomic mRNA synthesis
at 8 h p.i., with a more substantial block occurring in mutant nsp10-E2. However, by 12 h p.i., only nsp10-E2 and nsp10-U4 showed reductions in
subgenomic mRNA synthesis. Black-and-white hatched bars, RNA harvested at 8 h p.i.; black bars, RNA harvested at 12 h p.i. (C) Genomic RNA
analysis using primers to detect ORF1 cDNA showed that all five mutants were compromised in generating genomic RNA at 8 h p.i., with mutants
nsp10-E1, nsp10-E2, and nsp10-U4 exhibiting more extensive blocks in genomic RNA synthesis. Genomic RNA synthesis returned to wild-type
levels by 12 h p.i. in all mutants except nsp10-E2. See above for explanation of hatched and black bars. (D) Reductions of subgenomic and genomic
RNAs from three independent infections at the 8-h time point were compared and analyzed by the paired t test to test the null hypothesis that
the reduction in subgenomic mRNAs minus the reduction of genomic RNAs was equal to zero. The null hypothesis was not rejected for mutants
nsp10-E2 and nsp10-U1, suggesting that these mutants have an equal reduction in subgenomic and genomic RNAs. The null hypothesis was
rejected with P values of less than 0.05 for mutants nsp10-U3 and nsp10-U4, suggesting that these mutants are significantly more defective in
generating genomic RNAs than subgenomic mRNAs. Mutant nsp10-E1 appears to be more defective in subgenomic mRNA synthesis than in
genomic mRNA synthesis, although this difference was not significant (P value of 0.110). Black bars, genomic RNA; white bars, subgenomic
mRNA; , statistical significance. Error bars represent standard errors with a 95% confidence interval.
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sis, suggesting that nsp10 plays a critical role in viral RNA
regulation of subgenomic and genomic transcripts.
Replicase protein processing. To assess the impact of nsp10
mutations on polyprotein processing of viral replicase proteins,
we performed radiolabeled immunoprecipitations on infected
cell lysates to evaluate the processing and expression levels of
nsp10. DBT cells were infected with wt-icMHV and the viable
nsp10 mutants at an MOI of 2.0 PFU/cell, pretreated with
actinomycin D, and switched to Met-Cys-minus medium, and
the cultures were labeled with [35S]Cys-Met for 4 h between 8
and 9 h p.i. Cell lysates were fractionated into a crude nuclear
pellet and cytoplasmic supernatant. Both the cytoplasmic and
nuclear fractions were probed with antibodies directed against
nsp10 (VU128), separated on SDS-PAGE gels, and analyzed
by autoradiography to detect radiolabeled viral proteins. nsp10
was expressed and processed during infection with each viable
nsp10 mutant, although some variation in the amounts of
nsp10 was noted among the nsp10 mutant panel (Fig. 4A). For
example, mutant nsp10-E2 appeared to express more proteins
than all other viruses despite reduced levels of replication and
the transcription phenotypes noted above (Fig. 4A).
Current data suggest that nsp4-10/11 is expressed as a
polyprotein-processing precursor of 150 kDa known as p150,
which is subsequently processed by 3CLpro via cis or trans
cleavage into the individual replicase proteins (41, 47, 54). The
nsp10-E2 mutant contained two novel bands that registered at
30 kDa and 71 kDa, respectively. By size analyses, viral
precursor polyproteins containing nsp9-11 (29 kDa) and nsp7-
11(71 kDa) would be the only appropriately sized intermedi-
ates to be immunoprecipitated with anti-nsp10 antisera. These
data suggest that the nsp10-E2 mutation may cause subtle
changes in nsp4-10/11 polyprotein processing, allowing the vi-
sualization of the polyprotein precursor intermediates from
the C-terminal end of pp1a.
In addition to cytoplasmic lysates, crude nuclear pellets were
also probed with anti-nsp10 antibody (Fig. 4B) to determine if
ancillary processing intermediates were detectable. Bands cor-
responding to nsp10 as well as putative intermediates nsp10-11
(17 kDa), nsp9-11 (29 kDa), nsp8-11 (51 kDa), nsp7-11
(61 kDa), and nsp6-11 (92 kDa) were present in crude
nuclear lysates from nsp10-E2 (Fig. 4B). In addition to altered
processing of the polyprotein, alternate subcellular targeting of
mutant nsp10 could account for a reduction in RNA synthesis.
nsp10 replicase protein subcellular localization. To deter-
mine if the alanine-scanning mutations in nsp10 altered its
subcellular localization, IFAs were performed. Previous stud-
ies demonstrated that wild-type nsp10 colocalizes with N to
distinct punctuate foci in perinuclear regions that are thought
to be the site of the CoV replication complexes (Fig. 5A) (3)
and not with M, which localizes to sites of assembly. We
probed mock-infected and infected cells with antisera directed
against nsp10 and either M- or N-specific antibodies to deter-
mine if the panel of nsp10 mutants was targeted to sites of
replication similarly to the wild-type protein. The predominant
nsp10 signal was localized in perinuclear regions for each of
the mutants (data not shown for all mutants) (Fig. 5B). The
nsp10 signal was also detected to a lesser extent in the nucleus
of DBT cells infected with nsp10-E2 (Fig. 5B) and is consistent
with immunoprecipitation data from crude nuclear lysates for
nsp10-E2. In all cases, nsp10 mutants appeared to colocalize
predominantly to sites of viral replication at 6.5 h p.i. and were
not found in sites of particle maturation and assembly.
Mapping the mutations onto the structure. To identify key
residues on the structure of nsp10 that might alter its function,
the viable, CPE/RNA, and lethal mutants were modeled
onto the solved structure of SARS-CoV nsp10. Homology
models were generated for wt-icMHV nsp10 and each of the
FIG. 4. Immunoprecipitation analysis of nsp10 mutants. Cultures
of cells were infected with various mutants, radiolabeled at 4 h p.i. with
[35S]methionine-cysteine, and harvested at 9 h p.i. The lysates were
immunoprecipitated with anti-nsp10 antibody and separated by SDS-
PAGE. (A) Immunoprecipitation analysis of the cytoplasmic lysates
showed that nsp10 is expressed and processed in each mutant; how-
ever, mutants nsp10-U3 and nsp10-E1 demonstrate a reduction in
processed nsp10. In addition, nsp10-E1 shows a reduction in p150.
Additional products that are not present in any other virus immuno-
precipitated with nsp10-E2. These bands likely represent processing
intermediates. (B) The crude nuclear pellet was also immunoprecipi-
tated with anti-nsp10 antibody, and mutant nsp10-E2 shows the accu-
mulation of several novel products, which correspond in size to addi-
tional processing intermediates.
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16 mutants. The backbone of the SARS-CoV nsp10 structure
was then compared to the homology model of MHV nsp10
using the MatchMaker tool under the structure comparison
section of Chimera (15, 27), resulting in a calculated root mean
square distance of 0.207 Å. Each mutant was then analyzed in
two contexts: (i) by studying the wild-type residues on the
MHV homology model and (ii) by comparing those residues to
changes predicted by the homology model for each mutant.
General trends. Joseph et al. solved the SARS nsp10 struc-
ture at a resolution of 1.8 Å and reported that it is a single-
domain protein comprised of a pair of antiparallel N-terminal
helices stacked against an irregular sheet, which contains a
coil-rich C terminus, and two ZFs. nsp10 represents a novel
fold and is the first structural representative of this family of
zinc finger proteins found so far exclusively in CoVs (22, 23).
Mapping of all of the mutations onto the homology model of
wild-type MHV provided strong support for both ZFs being
essential for nsp10 function and, therefore, MHV replication.
In general, the core structure of nsp10 surrounding the ZFs
was resistant to mutagenesis, and all mutations in the region
were lethal (Fig. 6). This central core, which extends from
amino acid 65 through the C-terminal half of nsp10, is also
comprised of 27 residues that are identical among all known
CoVs and contains both ZFs. Loops that extend away from the
central core, for the most part, tolerated mutations resulting in
viable phenotypes. The CPE/RNA mutants were all glycine-
to-alanine replacements that occurred in the outer loops or in
H3 (Fig. 6).
DISCUSSION
Previous studies predicted that nsp10 acts as a cofactor in
the MHV replication complex (3, 28, 30, 41, 44, 50), which led
us to hypothesize that mutations in nsp10 could impact several
specific areas of viral RNA synthesis including but not limited
to (i) positive-strand synthesis, resulting in reductions of both
subgenomic and genomic RNAs; (ii) negative-strand synthesis,
resulting in reductions of minus-strand templates; and/or (iii)
polyprotein processing, resulting in reductions of essential pro-
teins or intermediates processed from the nascent polyprotein
that are essential for the formation of the replication complex.
To further examine the functional role of nsp10 in MHV RNA
transcription/replication, we applied a reverse-genetics approach
incorporating alanine-scanning mutations into the nsp10 gene
of the molecular clone of MHV based upon two strategies.
First, we hypothesized that conserved regions of nsp10 are
essential to its function, so we targeted single residues and a
disordered region that are strictly conserved in all CoVs (Fig.
1 and Table 2). Second, we hypothesized that charged residues
may provide polar targets on the molecule’s surface that facil-
itate binding to other proteins or nucleic acids; thus, pairs and
FIG. 5. Confocal IFA of nsp10 mutants. DBT cells were infected
with wt-icMHV and the panel of mutants at an MOI of 5 PFU/cell for
6.5 h and fixed in methanol. Cells were then dual labeled with anti-
nsp10 (-nsp10) and anti-N or anti-M to determine if nsp10 colocalizes
with N at sites of replication or with M at sites of viral assembly. (A) In
wt-icMHV, nsp10 colocalizes with N predominantly to perinuclear
foci, where the viral replication complex is thought to assemble. nsp10
clearly does not colocalize with M, a marker for viral assembly. (B) For
the panel of mutants, it appeared that nsp10 localized predominantly
at the same perinuclear structures as wt-icMHV, with incidental stain-
ing occurring in the nucleus in mutant nsp10-E2.
FIG. 6. Topology map of MHV nsp10 showing a conserved core
and all 16 mutations. The homology-modeled structure of nsp10 starts
with two antiparallel -helices, -helices 1 and 2 (H1 and H2), fol-
lowed by four -sheets (B1 to B4) and long loops and then two small
-helices, H3 and H4, which are important for ZF-1. After ZF-1, there
is another small -sheet (B5) followed by -helix 5 (H5) and then ZF-2
at the C-terminal end of nsp10. The central core is colored black, and
numbers represent amino acid positions in nsp10 of MHV. Filled
circles, viable mutants; filled diamonds, nonviable mutants; hollow
circles, CPE/RNA mutants; filled stars, ZF-1 and ZF-2. The central
core is highly conserved and resistant to mutagenesis, while the loops
on either side tolerate mutagenesis.
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triplets of charged amino acids were targeted. In all cases, the
targeted amino acid(s) was changed to alanine, as alanine
eliminates the side chain beyond the -carbon but does not
alter the main-chain conformation, nor does it impose extreme
electrostatic or steric effects (10). Of the 16 full-length mutant
viral cDNAs generated, eight constructs resulted in no detect-
able virus, three generated CPE/RNA phenotypes that were
lost with passage, and five viruses were rescued with viable
phenotypes and further characterized in this study. The high
number of nonviable constructs supports previous arguments
that nsp10 is essential for CoV replication.
RNA synthesis of each viable mutant was evaluated by anal-
yses of growth kinetics over 16 h and detection of subgenomic
versus genomic plus-strand RNA quantities at 8 and 12 h p.i.
Growth curve analysis demonstrated that all five viable mu-
tants were compromised in RNA synthesis, with all of them
showing reduced growth kinetics compared to those of wt-
icMHV (Fig. 2). This trend was confirmed by both Northern
blot and real-time PCR, which demonstrated that all five mu-
tants were reduced in RNA synthesis at 8 h p.i., although
steady-state levels of RNA became nearly equivalent by 12 h
p.i. in all mutants except nsp10-E2 and nsp10-U4. Interest-
ingly, mutant nsp10-E2 showed the largest reduction, with a
nearly 3-log reduction in subgenomic and genomic RNA at
both time points, while nsp10-U4 showed a more extensive
reduction in subgenomic RNA synthesis at the earlier time
point.
MHV-A59 is known to produce 100 subgenomic mRNAs
per genomic RNA, and this ratio remains constant throughout
the infectious cycle (39), although the ratio of the different
subgenomic mRNAs varies greatly, with mRNA-7 (N gene)
being the most abundant. In addition, negative strands com-
prise approximately 1% of the total RNA at any time (41).
Mutations that equally reduce subgenomic and genomic RNAs
but maintain this ratio would likely introduce a defect in global
positive-strand RNA synthesis or a defect in negative-strand
template synthesis. In our mutant panel, we observed pheno-
types that preserved this ratio as well as those that appeared to
alter this ratio with specific reductions in genomic and/or sub-
genomic RNA synthesis.
Comparisons of the reductions of subgenomic and genomic
RNAs for each mutant versus wt-icMHV at 8 h p.i. indicated
that mutants nsp10-E1, nsp10-U3, and nsp10-U4 demonstrated
differential reductions in subgenomic and genomic RNA syn-
thesis, suggesting that the ratio of subgenomic mRNAs per
genomic RNA was altered. In contrast, mutants nsp10-E2 and
nsp10-U1 had reductions that were equal in both cases (Fig.
3D), suggesting that RNA synthesis was reduced, but the ratio
of subgenomic mRNAs per genomic RNA remained constant
at 100 to 1. However, by 12 h p.i., only nsp10-E2 had sub-
genomic and genomic RNA levels significantly lower than that
of wt-icMHV, with nsp10-U4 genomic RNA synthesis recov-
ering to nearly wild-type levels and subgenomic RNA synthesis
recovering to less than a 1-log reduction.
Although it appears that ratios of subgenomic versus genomic
RNA eventually recover to wild-type levels by 12 h p.i., differ-
ential ratios are evident in mutants nsp10-E1, nsp10-U3, and
nsp10-U4 at earlier times of infection. It is worth noting that in
similar studies with arterivirus protein nsp11, some mutations
produced moderate but significant differences between genomic
and subgenomic RNA synthesis (36). This may be occurring at
early times of infection in some nsp10 mutants, perhaps due to
a defect in negative-strand template synthesis. Alternatively, a
mutation that altered the ability of RdRp template switching
could reduce subgenomic mRNA quantities and have no affect
on genomic minus- or plus-strand synthesis (31, 32). We note
that real-time and Northern blot analyses measure accumu-
lated levels of RNA and do not measure the actual rates of
subgenomic and genomic mRNA transcription.
These data show that four of five mutants exhibited delays in
global RNA synthesis at 8 h p.i. that were overcome by 12 h
p.i., whereas nsp10-E2 maintained global 3-log reductions
throughout. There are at least four mechanisms that could
account for global reductions of viral RNA synthesis in the
nsp10 mutants: (i) a specific defect in negative-strand or global
positive-strand synthesis, (ii) a defect in polyprotein processing
that impedes the maturation of the replication complex, (iii) a
reduction in the molar quantities of processed nsp10 leading to
a reduction in the number of functional replication complexes,
or (iv) mislocalization of mutated nsp10 proteins to alternative
cellular compartments.
Confocal IFA verified that the mislocalization of the mu-
tated forms of nsp10 did not occur, although ancillary staining
of nsp10 was detected in the nucleus of cells infected with
nsp10-E2 (Fig. 5B). This observation led us to examine viral
processing in both the cytoplasmic and nuclear fractions of
infected cells.
Operating under the hypothesis that mutations in nsp10
might impede the processing of pp1a/pp1ab by disrupting es-
sential contact sites required for protein-protein cis interac-
tions or by interfering with the ability of the polyprotein to fold
into a correct orientation to facilitate 3CLpro cleavage, immu-
noprecipitations were performed to detect nsp10 in the cyto-
plasmic and nuclear fractions of cells infected with each mu-
tant. In the cytoplasmic fraction, mature forms of nsp10 were
processed in each case although at various concentrations (Fig.
4A), whereas in the nuclear fraction, only mutant nsp10-E2
had detectable proteins (Fig. 4B). Interestingly, nsp10-E2 pro-
cessed novel proteins of 65 kDa and 29 kDa in the cytoplasmic
fraction (Fig. 4A), while in the nuclear fraction, proteins of 17
kDa, 29 kDa, 51 kDa, and 65 kDa were detected (Fig. 4B).
These novel proteins correlate in mass to putative intermedi-
ates nsp7-11 (65 kDa), nsp8-11 (51 kDa), nsp9-11 (29
kDa), and nsp10-11 (17 kDa) very well.
Although the processing of mature proteins from the nas-
cent polyprotein in MHV-A59 is not completely understood,
there is no evidence that these intermediates exist in wild-type
or mock infections (Fig. 4A). We hypothesize that nsp10-E2
impedes viral processing of the p150 intermediate, resulting in
novel processing intermediates that are either transient or non-
existent in wild-type MHV. These psuedoproforms probably
accumulate in excess in the cell and likely aggregate with the
membranes pulled down with the crude nuclear pellet, al-
though proteins that are 50 kDa and smaller are capable of
inefficiently traversing the nuclear pore complex in the absence
of active transport (2). Furthermore, the accumulation of ab-
errant processing intermediates reduces the number of func-
tional replication complexes, resulting in a global (3-log) re-
duction of genomic and subgenomic RNAs.
Support for this hypothesis was found in studies with yellow
VOL. 81, 2007 MHV nsp10 REGULATES VIRAL RNA SYNTHESIS 6365
fever and hepatitis A viruses, which have shown that mutations
distant from the polyprotein cleavage site and the active site of
the viral protease are capable of reducing proteolytic activity,
hypothetically by altering substrate conformation (9, 16). We
are currently generating the necessary reagents to verify that
these are intermediate forms, to further investigate the fate of
the p150 polyprotein during processing in mutant nsp10-E2,
and to discern the processing cascade and the exact identity of
the intermediates that are present at various times of infection.
Recent structural studies have solved the X-ray crystal struc-
ture of SARS-CoV nsp10 and identified a protein with a novel
fold containing two ZFs, predicted to be essential to nsp10
function (22, 51). We used the SARS nsp10 crystal structure to
generate homology models of MHV nsp10 and then mapped
our mutations onto the predicted structure. Of note, mutations
responsible for the phenotype of nsp10-E2 (D47A and H48A)
removed two charged residues predicted to extend to the sur-
face of nsp10. Removing these side chains appeared to alter
the loop region without ablating the nsp10 structure com-
pletely. Interestingly, both nsp10-E2 and the known tempera-
ture-sensitive mutant TS-LA6 [nsp10(Q65E)] map to the same
region on the structure of nsp10, in the loop region proximal to
the first ZF. In the case of nsp10-E2, replacing Asp47 and
His48 with alanines directly alters the hydrogen bonds Lys43-
His48, Asp47-Ala-49, and Asp47-Cys46, which allow the loop
to collapse inward, rearranging the surface. Replacing a glu-
tamine with glutamic acid at position 65, as in TS-LA6, adds a
negative charge to the surface of the protein and forces the
loop to extend outward, probably due to repulsion between
Glu65, Asp66, and Glu60, which are in the same proximity.
This allows a new hydrogen bond to form between Glu65 and
His48, which likely extend the loop outward. TS-LA6 has been
characterized as having a defect in negative-strand synthesis
(41), and we are currently investigating whether or not TS-LA6
shows a reduction in processing efficiency similar to nsp10-E2.
nsp10-U4 targeted a proline at position 59, which also maps
to the same region as nsp10-E2 and TS-LA6. We hypothesized
that changing this amino acid to alanine would provide more
helical character to this disordered region that is conserved
throughout the Coronavirus genus. The fact that this mutation
conferred differential reductions in genomic and subgenomic
RNA synthesis at 8 h p.i. suggests that this disordered region is
critical for the regulation of viral RNA synthesis, most likely by
interacting with another cofactor or viral RNA. In fact, disor-
dered regions have been implicated as being binding interfaces
in other studies (37).
In addition, the mutation to nsp10-U4 might alter the for-
mation of higher-order structures, particularly in conjunction
with mutant nsp10-E1. Changing the lysines to alanines in
mutant nsp10-E1 (K24A and K25A) removed positive poten-
tial from the surface of nsp10, potentially reducing its binding
capacity to another cofactor, or viral RNA. In addition, Lys25
has been implicated as being a key aliphatic residue that in-
teracts with Glu60 of a second nsp10 monomer to stabilize the
formation of a trimer. Four of these trimers are predicted to
interact to form a large dodecamer, which is hypothesized to
function as a transcription factor (51). However, replacing
Lys25 with alanine would remove the interacting side chain
and would likely ablate this interaction site. Additional resi-
dues stabilize this interface, and they include Val21 from one
monomer that interacts with Val57 and Thr58 of another (51).
Mutant nsp10-U4 (P59A) would also likely interfere with this
interface at the second interaction site because changing the
proline to alanine at position 59 would alter the rotameric
positions of neighboring residues 57, 58, and 60, all of which
have been predicted to be crucial for trimer formation. The
fact that both mutants nsp10-E1 and nsp10-U4 are viable sug-
gests that the dodecamer supercomplex may lack biological
relevance. In fact, this structure was solved using the nsp10-
nsp11 polyprotein, and experiments in our laboratory have
demonstrated that cleavage of nsp11 from nsp10 is essential
for replication (Deming et al., unpublished). Although it was
shown that nsp11 extends away from the dodecamer (51), it is
not known if this supercomplex can form in the absence of
nsp11. A second solved structure of nsp10 suggests that nsp10
may form homodimers or homotrimers (22).
Mapping all 16 of our mutations onto the homology model
of MHV nsp10 provided important insights into its structure.
First, mutations that resulted in lethal phenotypes occurred
within or near the ZFs. ZFs are protein domains in which Zn2
contributes to structural stability by binding to residues in the
structure to stabilize the domain. There are several classes of
ZFs, and these are found in a variety of proteins of diverse
function, including proteins involved in the replication and
repair of nucleic acids, transcription and translation, cellular
signaling and metabolism, and cell proliferation and apoptosis.
ZFs most frequently function as interaction sites for the bind-
ing of other proteins, nucleic acids, or small molecules (for a
recent review, see reference 23). The residues that bind zinc in
SARS-CoV nsp10 are strictly conserved throughout the Coro-
navirus genus and include residues Cys74, Cys77, His83, and
Cys90, which bind zinc to form ZF-1, and residues Cys117,
Cys120, Cys128, and Cys103, which bind zinc to form ZF-2.
The fact the lethal mutations occurred in or near the ZFs
indicates that both ZF motifs are critical for infectivity and
RNA synthesis in cell culture. Furthermore, in agreement with
data reported previously by Joseph et al. and Su et al. (22, 51),
our data suggest that the C-terminal half of nsp10 comprises a
central core, which spans amino acids 65 to 130 and provides
the structure necessary for the formation of both ZFs (Fig. 6).
Analyses of the homology models suggest that lethal mutations
that mapped within the central core altered the local structural
landscape, which prevented the ZFs from forming. We ob-
served three such disruptions. The first disruption, replace-
ment of the essential residues involved in Zn2 binding, as in
mutant nsp10-E5 (Q82A and H83A), was lethal. Second, tar-
geting residues that hydrogen bond directly to the four resi-
dues that bind Zn2 in both ZFs appears to disrupt the for-
mation of the domain. Lethal mutant nsp10-E4 mutates an
Arg78-Ser79-Arg80 motif near ZF-1 in which both arginine
residues hydrogen bond directly to the residues that bind Zn2
(Arg78-Cys74 and Arg80-Cys77). Third, altering residues prox-
imal to each ZF probably disrupts the structure enough to
prevent ZF formation. Lethal mutants nsp10-E6 (K104A
and D105A), nsp10-E7 (H113A and D114A), and nsp10-E8
(R123A and D124A) occur near the ZFs and alter hydrogen
bonding. These observations suggest that the structure of the
central core is essential for the formation of the ZF domains
and provide strong evidence that the ZFs are imperative for
nsp10 function.
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The N-terminal region of nsp10, which contains mostly loops
that extend away from the structural core of nsp10, tolerated
mutagenesis. All of the viable mutants were well away from the
ZFs and targeted residues that were not involved in maintain-
ing the local structure necessary for the folding of these do-
mains. However, in all cases, these viable mutations had an
impact on viral RNA synthesis, suggesting that nsp10 is a
critical regulator of viral RNA synthesis.
The results presented in this paper suggest that nsp10 plays
a critical role in the regulation of viral RNA synthesis as well
as a potential secondary role in polyprotein processing (Fig. 7A
and B). Future experiments designed to measure full-length
and subgenomic-length replicative-form RNAs and quantita-
tion of negative strands for each viable mutant will help elu-
cidate the exact role of nsp10 in MHV positive- and negative-
strand RNA synthesis. The role of nsp10 in processing is likely
by cis interactions with a binding partner within the precursor
polyprotein. A putative binding site between amino acid posi-
tions 48 and 65, which includes the conserved disordered re-
gion, may facilitate this interaction. Another possibility is that
this region of nsp10 maintains the amino acids necessary for
the p150 intermediate to adopt the correct fold to allow other
cis interactions, which facilitate the autocleavage of the polypro-
tein by 3CLpro. Pulse-chase experiments have been designed
to further examine the fate of the p150 intermediate in
nsp10-E2 infection to verify that processing is reduced in that
mutant. Additionally, mapping the mutations generating lethal
phenotypes onto the structure of nsp10 supports the hypothesis
that both ZFs are essential for replication and demonstrates
that a conserved central core maintains the functional domain
of nsp10.
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